MicroRNA-494 inhibits breast cancer progression by directly targeting PAK1

被引:81
|
作者
Zhan, Meng-Na [1 ,2 ]
Yu, Xiao-Ting [3 ]
Tang, Jun [4 ,5 ]
Zhou, Ci-Xiang [1 ,2 ]
Wang, Chen-Long [1 ,2 ]
Yin, Qian-Qian [1 ,2 ]
Gong, Xiu-Feng [1 ,2 ]
He, Ming [1 ,2 ]
He, Jian-Rong [6 ]
Chen, Guo-Qiang [1 ,2 ,4 ,5 ]
Zhao, Qian [1 ,2 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Dept Pathophysiol, Key Lab Cell Differentiat & Apoptosis,Natl Minis, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Shanghai, Peoples R China
[3] Tongji Univ, Sch Med, Tong Ji Hosp, Dept Pathol, Shanghai, Peoples R China
[4] Shanghai Jiao Tong Univ, Sch Med, Inst Hlth Sci, Shanghai, Peoples R China
[5] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China
[6] Shanghai Jiao Tong Univ, Rui Jin Hosp, Dept Gen Surg, Sch Med, Shanghai, Peoples R China
来源
CELL DEATH & DISEASE | 2017年 / 8卷
基金
美国国家科学基金会;
关键词
EPITHELIAL-MESENCHYMAL TRANSITION; IN-VITRO; ACTIVATION; EXPRESSION; INVASION; MIR-494; PROLIFERATION; TUMORIGENESIS; PROTRUSION; HALLMARKS;
D O I
10.1038/cddis.2016.440
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
MicroRNA (miRNA) is involved in the progression and metastasis of diverse human cancers, including breast cancer, as strong evidence has been found that miRNAs can act as oncogenes or tumor suppressor genes. Here, we show that miR-494 is decreased in human breast cancer specimens and breast cancer cell lines. Ectopic expression of miR-494 in basal-like breast cancer cell lines MDA-MB-231-LUC-D2H3LN and BT-549 inhibits clonogenic ability and metastasis-relevant traits in vitro. Moreover, ectopic expression of miR-494 suppresses neoplasm initiation as well as pulmonary metastasis in vivo. Further studies have identified PAK1, as a direct target gene of miR-494, contributes to the functions of miR-494. Remarkably, the expression of PAK1 is inversely correlated with the level of miR-494 in human breast cancer samples. Furthermore, re-expression of PAK1 partially reverses miR-494-mediated proliferative and clonogenic inhibition as well as migration and invasion suppression in breast cancer cells. Taken together, these findings highlight an important role for miR-494 in the regulation of progression and metastatic potential of breast cancer and suggest a potential application of miR-494 in breast cancer treatment.
引用
收藏
页码:e2529 / e2529
页数:11
相关论文
共 50 条
  • [41] Antisense Oligonucleotide Inhibition of MicroRNA-494 Halts Atherosclerotic Plaque Progression and Promotes Plaque Stabilization
    van Ingen, Eva
    Foks, Amanda C.
    Kroner, Mara J.
    Kuiper, Johan
    Quax, Paul H. A.
    Bot, Ilze
    Nossent, Anne Yael
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2019, 18 : 638 - 649
  • [42] Erianin inhibits the progression of pancreatic cancer by directly targeting AKT and ASK1
    Liu, Ruxue
    Qiu, Minghan
    Deng, Xinxin
    Zhang, Meng
    Gao, Zhanhua
    Wang, Yayun
    Mei, Hanwei
    Zhai, Mengting
    Zhang, Qiaonan
    Hao, Jie
    Yang, Zhen
    Wang, Huaqing
    CANCER CELL INTERNATIONAL, 2024, 24 (01)
  • [43] MicroRNA-137 Inhibits Cancer Progression by Targeting Del-1 in Triple-Negative Breast Cancer Cells
    Lee, Soo Jung
    Jeong, Jae-Hwan
    Kang, Seung Hee
    Kang, Jieun
    Kim, Eun Ae
    Lee, Jeeyeon
    Jung, Jin Hyang
    Park, Ho Yong
    Chae, Yee Soo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (24)
  • [44] Nischarin, an integrin α5 binding protein, forms complexes with Rac1 and PAK1 and inhibits PAK1 activation
    Reddig, PJ
    Alahari, SK
    Juliano, RL
    MOLECULAR BIOLOGY OF THE CELL, 2002, 13 : 348A - 348A
  • [45] MiR-485 Inhibits Epithelial-Mesenchymal Transition, Migration, and Invasion of Pancreatic Cancer Cells by Directly Repressing PAK1
    Zhang, Z. K.
    Li, J.
    Tian, X. D.
    Yang, Y. M.
    PANCREAS, 2019, 48 (10) : 1562 - 1562
  • [46] microRNA-96 protects pancreatic -cell function by targeting PAK1 in gestational diabetes mellitus
    Li, Lei
    Wang, Shan
    Li, Hongyan
    Wan, Jipeng
    Zhou, Qian
    Zhou, Yu
    Zhang, Chunhua
    BIOFACTORS, 2018, 44 (06) : 539 - 547
  • [47] PAK1 is a breast cancer oncogene that coordinately activates MAPK and MET signaling
    Shrestha, Y.
    Schafer, E. J.
    Boehm, J. S.
    Thomas, S. R.
    He, F.
    Du, J.
    Wang, S.
    Barretina, J.
    Weir, B. A.
    Zhao, J. J.
    Polyak, K.
    Golub, T. R.
    Beroukhim, R.
    Hahn, W. C.
    ONCOGENE, 2012, 31 (29) : 3397 - 3408
  • [48] PAK1 is a breast cancer oncogene that coordinately activates MAPK and MET signaling
    Y Shrestha
    E J Schafer
    J S Boehm
    S R Thomas
    F He
    J Du
    S Wang
    J Barretina
    B A Weir
    J J Zhao
    K Polyak
    T R Golub
    R Beroukhim
    W C Hahn
    Oncogene, 2012, 31 : 3397 - 3408
  • [49] MicroRNA-485 inhibits malignant biological behaviour of glioblastoma cells by directly targeting PAK4
    Mao, Ke
    Lei, Ding
    Zhang, Heng
    You, Chao
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2017, 51 (05) : 1521 - 1532
  • [50] MicroRNA-612 inhibits cervical cancer progression by targeting NOB1
    Jin, Yang
    Zhou, Xu
    Yao, Xiaoxiao
    Zhang, Zhuo
    Cui, Manhua
    Lin, Yang
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2020, 24 (05) : 3149 - 3156